
Disrupted striatal neuron inputs and outputs in Huntington's disease
Author(s) -
Reiner Anton,
Deng YunPing
Publication year - 2018
Publication title -
cns neuroscience and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 69
eISSN - 1755-5949
pISSN - 1755-5930
DOI - 10.1111/cns.12844
Subject(s) - neuroscience , huntington's disease , basal ganglia , striatum , medium spiny neuron , dystonia , thalamus , chorea , huntingtin , biology , deep brain stimulation , indirect pathway of movement , psychology , disease , parkinson's disease , medicine , pathology , central nervous system , dopamine
Summary Huntington's disease ( HD ) is a hereditary progressive neurodegenerative disorder caused by a CAG repeat expansion in the gene coding for the protein huntingtin, resulting in a pathogenic expansion of the polyglutamine tract in the N‐terminus of this protein. The HD pathology resulting from the mutation is most prominent in the striatal part of the basal ganglia, and progressive differential dysfunction and loss of striatal projection neurons and interneurons account for the progression of motor deficits seen in this disease. The present review summarizes current understanding regarding the progression in striatal neuron dysfunction and loss, based on studies both in human HD victims and in genetic mouse models of HD . We review evidence on early loss of inputs to striatum from cortex and thalamus, which may be the basis of the mild premanifest bradykinesia in HD , as well as on the subsequent loss of indirect pathway striatal projection neurons and their outputs to the external pallidal segment, which appears to be the basis of the chorea seen in early symptomatic HD . Later loss of direct pathway striatal projection neurons and their output to the internal pallidal segment account for the severe akinesia seen late in HD . Loss of parvalbuminergic striatal interneurons may contribute to the late dystonia and rigidity.